Bodal Chemicals Schedules Q2 FY27 Results for November 3

Bodal Chemicals Limited will consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026, at its board meeting on November 3, 2026, following a first quarter in which revenue rose 57% year on year to ₹715.19 crore.

When will Bodal Chemicals announce its Q2 FY27 results?

Bodal Chemicals has scheduled a board meeting for November 3, 2026, to approve its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company has also identified November 3 as the date for its Q2 FY27 result announcement in its corporate-action calendar.

The scheduled release follows the conclusion of the September quarter on September 30. The company had earlier informed exchanges that its trading window for dealing in its securities would close from October 1, 2026, ahead of the declaration of the September-quarter and half-year financial results.

Under the company’s disclosure, the trading window will remain closed until 48 hours after the financial results are declared. This restriction is intended to prevent trading by designated persons while they may possess unpublished price-sensitive information, in line with SEBI insider-trading regulations.

An earlier communication on the window closure had said the board-meeting date would be separately conveyed to the exchanges. The November 3 board meeting provides that date and sets the immediate reporting milestone for shareholders and investors.

What did Bodal Chemicals report in the June 2026 quarter?

Bodal Chemicals reported total income of ₹715.19 crore for the quarter ended June 30, 2026, compared with ₹458.25 crore in the corresponding quarter a year earlier. Net sales turnover rose to ₹709.04 crore from ₹454.20 crore, while other income stood at ₹6.15 crore.

The company reported profit after tax of ₹30.38 crore for the June quarter, against ₹9.53 crore a year earlier. Reported earnings per share were ₹2.41, compared with ₹0.76 in the first quarter of the previous financial year. Net income was therefore up 219% year on year, according to the supplied earnings update.

Operating performance also improved from the year-earlier level. EBITDA was ₹75.10 crore, compared with ₹51.66 crore in the June 2025 quarter, while EBIT was ₹57.69 crore against ₹34.15 crore. Interest expense declined to ₹18.57 crore from ₹21.63 crore despite the higher scale of operations.

Profitability was also stronger than the preceding quarter in some measures. However, PAT of ₹30.38 crore was below ₹32.06 crore recorded in the March 2026 quarter. The September-quarter results will provide the next reported update on revenue, costs, borrowing expenses and profitability.

How did Bodal Chemicals perform in FY26?

Bodal Chemicals reported consolidated revenue of ₹2,053.89 crore for the year ended March 31, 2026, an increase of 17% from the preceding year. The company attributed the revenue performance to volume growth and an improved product mix, with Basic Chemicals and Dye Intermediates cited as important contributors.

FY26 EBITDA increased 19% to ₹202.85 crore. EBITDA margin improved to 9.9% from 9.7%, indicating a modest expansion in operating profitability despite the company operating in chemical segments where product mix and input costs can affect margins.

Profit after tax for FY26 stood at ₹47.83 crore, up 158.5% year on year. The annual report also said export revenue accounted for 25% of consolidated revenue, with sales across Europe, the United States and Asia-Pacific.

The annual report included audited standalone and consolidated results for the March 2026 quarter and full year. The auditor issued an unmodified opinion, reported no material uncertainties, and stated that internal controls were effective, according to the information provided.

What financial factors will investors monitor in the September quarter?

Investors will monitor whether the growth in sales and profitability reported in the June quarter continued through the September quarter. Revenue, EBITDA, PAT, margin movement, interest cost and working-capital indicators will be relevant because the company’s June-quarter performance showed a sharp improvement from the year-earlier period.

Debt reduction is another reported financial factor. Net debt declined to ₹792.70 crore at the end of FY26 from ₹892.17 crore a year earlier, while cash stood at ₹7.46 crore. The September-quarter filing may provide an updated view of borrowings, finance costs and liquidity, although the company has not disclosed any financial guidance in the supplied announcements.

The company’s export share will also remain relevant to its operating mix. Exports represented 25% of FY26 consolidated revenue, and Bodal Chemicals has identified markets in Europe, the US and Asia-Pacific. The supplied disclosures do not provide September-quarter export figures or a forecast for export demand.

No share-price movement, earnings estimate or management outlook was provided in the available material. As a result, the November 3 announcement will be the formal source for updated financial performance and any accompanying board-approved disclosures.

Conclusion

Bodal Chemicals enters its November 3 board meeting after reporting substantial year-on-year improvement in its June-quarter sales, EBITDA and profit. FY26 results also showed revenue growth, a higher EBITDA margin, lower net debt and a 25% export contribution, providing the financial context for the September-quarter update.

The next item to watch is the company’s unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. Investors will be able to assess whether the June-quarter revenue growth, profit improvement and lower interest burden continued, while the trading window is set to reopen 48 hours after the results are declared.